BIOMAT Database Logo BIOMAT Database Logo

Synthesis and evaluation of S-acyl-2-thioethyl esters of modified nucleoside 5'-monophosphates as inhibitors of hepatitis C virus RNA replication. 2005

Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
Department of Medicinal Chemistry, ISIS Pharmaceuticals, 2292 Faraday Avenue, Carlsbad, California 92008, USA. tprakash@isisph.com

Several triphosphates of modified nucleosides (1-6) were identified as inhibitors (IC(50) = 0.08-3.8 microM) of hepatitis C virus RNA-dependent RNA polymerase (RdRp). Although the initial SAR developed by determining the ability of the triphosphates to inhibit the in vitro activity of the HCV RdRp identified several potent inhibitors, none of the corresponding nucleosides exhibited significant inhibitory potency in a cell-based replicon assay. To improve upon the activity, bis(tBu-S-acyl-2-thioethyl) nucleoside 5'-monophosphate esters (7-12) were synthesized, and these derivatives exhibited improved potency compared to the corresponding nucleosides in the cell-based assay. Analysis of the intracellular metabolism demonstrated that the S-acyl-2-thioethyl (SATE) prodrug is metabolized to the 5'-triphosphate 40- to 155-fold more efficiently compared to the corresponding nucleoside. The prodrug approach involving bis(tBuSATE)cytidine 5'-monophosphate ester significantly reduced the deamination of cytidine derivatives by cellular deaminases. Additionally, chromosomal aberration studies with the SATE prodrug in cells showed no statistically relevant increase in aberrations compared to the concurrent controls.

UI MeSH Term Description Entries
D010755 Organophosphates Carbon-containing phosphoric acid derivatives. Included under this heading are compounds that have CARBON atoms bound to one or more OXYGEN atoms of the P( Organophosphate,Phosphates, Organic,Phosphoric Acid Esters,Organopyrophosphates,Acid Esters, Phosphoric,Esters, Phosphoric Acid,Organic Phosphates
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey
D003562 Cytidine A pyrimidine nucleoside that is composed of the base CYTOSINE linked to the five-carbon sugar D-RIBOSE. Cytosine Ribonucleoside,Cytosine Riboside,Ribonucleoside, Cytosine,Riboside, Cytosine
D003568 Cytidine Monophosphate Cytidine (dihydrogen phosphate). A cytosine nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. CMP,Cytidylic Acid,2'-CMP,3'-CMP,Cytidylic Acids,2' CMP,3' CMP,Acid, Cytidylic,Acids, Cytidylic,Monophosphate, Cytidine
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012324 RNA-Dependent RNA Polymerase An enzyme that catalyses RNA-template-directed extension of the 3'- end of an RNA strand by one nucleotide at a time, and can initiate a chain de novo. (Enzyme Nomenclature, 1992, p293) Nucleoside-Triphosphate:RNA Nucleotidyltransferase (RNA-directed),RNA Replicase,RNA-Dependent RNA Replicase,RNA-Directed RNA Polymerase,RNA Dependent RNA Polymerase,RNA Dependent RNA Replicase,RNA Directed RNA Polymerase,RNA Polymerase, RNA-Dependent,RNA Polymerase, RNA-Directed,RNA Replicase, RNA-Dependent,Replicase, RNA,Replicase, RNA-Dependent RNA

Related Publications

Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication.
August 2011, Bioorganic & medicinal chemistry,
Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs.
April 2003, The Journal of biological chemistry,
Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
Synthesis and evaluation of C-5 modified 2'-deoxyuridine monophosphates as inhibitors of M. tuberculosis thymidylate synthase.
November 2015, Bioorganic & medicinal chemistry,
Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
Synthesis and evaluation of optically pure dioxolanes as inhibitors of hepatitis C virus RNA replication.
December 2003, Bioorganic & medicinal chemistry letters,
Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
Nucleoside analog inhibitors of hepatitis C virus replication.
March 2006, Infectious disorders drug targets,
Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir.
January 1999, Antiviral research,
Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
Synthesis and evaluation of 5'-modified 2'-deoxyadenosine analogues as anti-hepatitis C virus agents.
August 2008, Bioorganic & medicinal chemistry letters,
Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication.
May 2007, Bioorganic & medicinal chemistry letters,
Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
Synthesis, molecular modeling, and biological evaluation of novel benzimidazole derivatives as inhibitors of hepatitis C virus RNA replication.
January 2014, Chemical & pharmaceutical bulletin,
Thazha P Prakash, and Marija Prhavc, and Anne B Eldrup, and P Dan Cook, and Steven S Carroll, and David B Olsen, and Mark W Stahlhut, and Joanne E Tomassini, and Malcolm MacCoss, and Sheila M Galloway, and Catherine Hilliard, and Balkrishen Bhat
Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication.
March 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!